Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07100106RecruitingPhase 1/Phase 2
Study of GDC-4198 alone or with giredestrant for advanced breast cancer
This trial tests a new treatment (GDC-4198) alone or with another drug (giredestrant) compared to a standard combination (abemaciclib and giredestrant) for people with advanced hormone receptor-positive, HER2-negative breast cancer that has progressed after previous treatments.
Huntsville, AlabamaAges 18 years+ - NCT06670677Recruiting
Blood pressure monitoring for early heart risk awareness
This study is testing whether a blood pressure monitoring system called Aktiia can help people become aware of high blood pressure early and predict heart risks. It involves using a smartphone and a wrist bracelet (or just the phone's camera) to take blood pressure readings.
LausanneAges 21–85 - NCT06757504RecruitingPhase 2
Testing TTYP01 tablets for autism in kids and teens
This study tests an investigational tablet (TTYP01) to see if it can help adolescents and children with autism spectrum disorder (ASD). The goal is to find out if the drug improves symptoms and is safe for this age group.
BeijingAges 6–16 - NCT06958679RecruitingPhase 1
Study of SYS6005 for advanced solid tumors and lymphomas
This study tests a new drug (SYS6005) that targets a protein called ROR1 on certain cancer cells. It is for people with advanced solid tumors or B-cell lymphomas that have stopped responding to other treatments.
TianjinAges 18 years+ - NCT06969950RecruitingPhase 2
A study on reducing doctor burnout
This trial tests a program to help physicians feel better at work. It studies whether the intervention can reduce burnout in doctors who provide direct patient care.
Providence, Rhode IslandAges 18 years+ - NCT06963853Recruiting
Study of infection and body chemicals in dialysis patients with sepsis
This study looks at germs and body chemicals in dialysis patients who are in the hospital with sepsis. The goal is to learn more about how these factors affect recovery.
Nahariya, IsraelAges 18 years+ - NCT05548621Recruiting
Using shared decision-making tools for kidney cancer care
This study tests whether a shared decision-making approach—using decision aids and guided discussions—helps people make better choices for kidney cancer treatment. It may help you feel more informed and involved when you and your care team decide on next steps.
Nieuwegein, UtrechtAges 18 years+ - NCT07094776Enrolling by invitation
MG53 protein levels in women with PCOS
This study measures a protein called MG53 in the blood of women with and without PCOS to see if it could be a marker for the condition. If you have PCOS and are not taking certain medications, you may be able to join and help researchers better understand the disease.
Gaziosmanpaşa, IstanbulAges 18–45 - NCT07086443RecruitingPhase 4
Testing a new wound therapy for diabetic foot ulcers
This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.
Monroeville, PennsylvaniaAges 18 years+ - NCT07090161RecruitingPhase 2
Study of iloperidone for uncontrolled high blood pressure
This trial tests if iloperidone can lower blood pressure in people whose high blood pressure is not controlled by current medications. You may qualify if your blood pressure is still high after weeks of treatment.
Phoenix, ArizonaAges 18–65 - NCT07091825Recruiting
Lubricating drops for rigid gas permeable contact lens wearers
This trial tests a new lubricating eye drop for people who wear rigid gas permeable (RGP) contact lenses. The drops are meant to make wearing the lenses more comfortable and less dry.
Beijing, Beijing MunicipalityAges 8 years+ - NCT07088926RecruitingPhase 2
Study of a new drug for bronchiectasis with chronic pseudomonas infection
This study tests an investigational drug given through an IV to see if it can reduce lung infections and flare-ups in people with bronchiectasis who have a chronic pseudomonas infection. Participation may help improve symptoms and quality of life.
Orange, CaliforniaAges 12 years+ - NCT07086105RecruitingPhase 1
Study of Adze1.C for advanced melanoma
This trial tests a new injected virus therapy (Adze1.C) for people with advanced melanoma that hasn't responded to other treatments. The virus is designed to attack tumors directly and may help your immune system fight the cancer.
Southport, QueenslandAges 18 years+ - NCT07089836Recruiting
Syphilis blood test study for at-risk and healthy people
This study tests two new blood tests for syphilis. It compares them to approved tests using blood from people who may have or had syphilis, including pregnant women, HIV-positive people, and healthy volunteers.
Lancaster, CaliforniaAges 13 years+ - NCT07090759RecruitingPhase 3
Test of new drug for hepatitis B not fully controlled by current treatment
This trial tests a new drug called GST-HG141 for people with chronic hepatitis B whose virus is still active despite taking standard antiviral pills. It aims to see if the new drug can better control the virus.
Hangzhou, ZhejiangAges 18–70 - NCT07093138RecruitingPhase 4
CBD cream for migraine attacks
This trial tests whether a cream made with cannabidiol (CBD) can help stop migraine attacks. It is for people aged 18 to 55 who have had migraines for at least a year and get 2 to 8 attacks per month.
TehranAges 18–55 - NCT07086313RecruitingPhase 2/Phase 3
Testing a new ADHD drug for children
This trial tests an experimental drug (EB-1020) for children with ADHD. It aims to see if the drug is safe and effective in reducing ADHD symptoms.
SapporoAges 6–17 - NCT07089238Recruiting
Citicoline for mood in healthy adults
This study tests whether a supplement called citicoline can improve mood in healthy adults who have some mild mood disturbance. It is designed to see if taking citicoline leads to a better mood.
Canfield, OhioAges 21–65 - NCT06885853Recruiting
Long-term immune response to mpox booster in men on PrEP
This study tests how well a booster dose of the MVA-BN mpox vaccine keeps working over time in men who are on or starting PrEP for HIV prevention.
Paris, ParisAges 18 years+ - NCT07092228Recruiting
Virtual reality and plyometrics for teen girls with PCOS
This trial tests whether combining virtual reality with jump-training (plyometrics) helps teenage girls with PCOS improve their exercise ability. It aims to find a fun and effective way to get active.
IsmailiaAges 13–18 - NCT07090070Recruiting
Treatment study for p53 mutant oral cancer and precancers
This trial tests different treatments for people with oral cancer or precancerous lesions that have a p53 mutation. It aims to find the best approach for early-stage disease to prevent progression.
Vancouver, British ColumbiaAges 18 years+ - NCT07095335Enrolling by invitation
Nursing students and faculty racism simulation study
This trial tests a virtual simulation to help nursing students and faculty recognize and handle racism and hidden bias. It may help participants practice responding to these situations in a safe, educational setting.
Kingston, OntarioAges 18 years+ - NCT07094581Recruiting
How adenoid size affects chewing muscle in children
This study uses ultrasound to see if enlarged adenoids affect the masseter muscle (a chewing muscle) in children. It may help doctors understand how breathing problems during sleep or mouth breathing impact jaw muscles.
Aydin, EfelerAges 3–8 - NCT07088081Enrolling by invitation
Immunotherapy drugs for advanced liver cancer
This trial tests two types of immunotherapy (atezolizumab with bevacizumab or durvalumab with tremelimumab) for people with advanced liver cancer that hasn't been treated with systemic therapy before. It aims to see if these treatments are safe and effective.
Cairo, AbbasyaAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.